FDA facing backlash over decision to halt us of two antibody treatments
Pfizer says it is testing an omicron-specific vaccine booster. This comes as the FDA faces backlash over its decision to halt the use of two antibody treatments.
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old. That’s according to a person familiar with the matter who spoke on the condition of anonymity to discuss sensitive regulatory issues.
Pfizer says it is testing an omicron-specific vaccine booster. This comes as the FDA faces backlash over its decision to halt the use of two antibody treatments.
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
The Centers for Disease Control and Prevention has signed off on two measures to increase access to additional doses of the Pfizer coronavirus vaccine.
Even with the expansion of Pfizer’s booster shots, coronavirus cases are still rapidly spreading across the county.
Parents with children under 5-years-old will have to wait a bit longer for a COVID-19 vaccine for their kids.
Ahead of the Christmas holiday, officials are scrambling to combat the fast spreading omicron variant. This comes as the FDA issues emergency use authorization for Pfizer’s COVID-19 treatment pill.
The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.
The CDC has updated its recommendations on COVID-19 vaccines after its vaccine advisors met on Thursday. This comes as the Omicron variant continues to spread in the U.S.
Data is still coming in on vaccines versus the Omicron variant.